Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

K2 Therapeutics secures US$50 million seed round to support development of its assets and appoints Huang Ying as CEO.

PRIVATEAug 11, 2026•about 5 hours ago

Amount Raised

$50 Million

Round Type

Seed

SingaporeBiotechnology

Investors

Mpm Bio Impact

Description

Singapore-based biotech K2 Therapeutics announced on August 11 that it has secured a US$50 million seed round. The funding will support the expansion of K2 Therapeutics’ portfolio and advancement of its assets. The round was seeded by MPM BioImpact. Huang Ying has been appointed as the new CEO to lead the company's growth.

Company Information

Company

K2 Therapeutics

Location

Singapore

About

K2 Therapeutics is a Singapore-based biotech company focused on identifying and translating assets into medicines. Founded by MPM BioImpact, it aims to unlock potential in medicine to improve and extend lives. The company operates under a hub-and-spoke model to gain a competitive edge in the biotech industry.

Predictive Intelligence
Strategic

ML-powered predictions for K2 Therapeutics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.